Evidence for a seasonal variation in the ability of exogenous melatonin to suppress prolactin secretion in the mare.
In seasonally breeding species photoperiodic information is thought to be conveyed to the reproductive and prolactin axis via changes in circulating concentrations of melatonin. For some species, a constant melatonin stimulus is perceived as a short day, whereas in others no photoperiodic information is provided. In the mare, a preliminary study demonstrated that constant administration of melatonin did not modify prolactin secretion, suggesting that this treatment regimen failed to provide photoperiodic information. To further investigate this proposal and to investigate an alternative explanation, namely a seasonal variation in response to melatonin, 4 experiments were performed. In experiments 1-3, the effects of constant administration of melatonin on prolactin secretion were investigated. In each study the time of treatment initiation varied beginning before the summer solstice, (May 9; Exp. 1), at the autumnal equinox (Sept. 21; Exp. 2) or the winter solstice (Dec. 21; Exp. 3). In Experiment 4, melatonin was administered as a timed daily injection (5 PM) for 6 months, beginning at the summer solstice (June 21). Constantly elevated physiological concentrations of melatonin (expts. 1-3) and an extended nighttime elevation of melatonin (exp. 4) suppressed prolactin concentrations only during the spring and early summer months (April-August). At other times during the year prolactin concentrations were similar to untreated mares. In the presence of a continuous melatonin implant the circannual rhythm of prolactin secretion was not disturbed. The results suggest that the prolactin axis of the mare is sensitive to an inhibitory melatonin signal during a restricted period of time and that at other times is refractory to this signal.
Fitzgerald
B P
BP
Department Veterinary Science, Maxwell Gluck Equine Research Center, University of Kentucky, Lexington, KY 40504-0099, USA. bfitz@pop.uky.edu
Davison
L A
LA
McManus
C J
CJ
D000818:Animals; D020099:Coated Materials, Biocompatible; D004129:Dimethylpolysiloxanes; D004343:Drug Implants; D005260:Female; D006736:Horses / Q000502:physiology*; D007279:Injections, Subcutaneous / Q000662:veterinary; D008550:Melatonin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D017440:Photoperiod; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D011863:Radioimmunoassay / Q000662:veterinary; D011897:Random Allocation; D012621:Seasons; D012828:Silicones
D020099:Coated Materials, Biocompatible; D004129:Dimethylpolysiloxanes; D004343:Drug Implants; D012828:Silicones; C013830:baysilon; D011388:Prolactin; D008550:Melatonin